Company intelligence / Profile preview
Avecho Biotechnology
Clayton, Victoria, Australiaavecho.com.au ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Phase 3
01
Overview
Developing TPM®-enhanced formulations including a Phase III CBD soft-gel for insomnia, topical cannabinoids for osteoarthritis, and transdermal opioids. Markets diclofenac gel in Asia through partners.
- Therapeutic areas
- ImmunologyPsychiatryNeurologyRheumatology
- Modalities
- Small moleculesTopical formulationsTransdermal patchesOral soft-gel capsules
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Novartis India (Voveran®TPM Gel)Themis Medicare (Instanac®TPM Gel)Ashland Global Holdings Inc. (Vital ET® licensing)
Beyond the preview
Go deeper on Avecho Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avecho Biotechnology.